Clinical Trials
8 trialsNCT01254864 2025-01-27
Maximal Androgen Depletion Followed by Randomization of Maximal Androgen Ablation With Molecular Targeted Therapies
M.D. Anderson Cancer Center
Phase 2 Completed
NCT00599313 2018-10-25
Phase II Sunitinib Prog Met AIPC
US Oncology Research
Phase 2 Completed
NCT00631527 2015-01-29
Sunitinib Malate, Hormone Ablation and Radiation Therapy in Patients With Prostate Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT00672594 2014-08-04
Study of Sunitinib Malate in Patients With Newly Diagnosed Prostate Cancer Prior to Prostatectomy
Duke University
Phase 2 Completed
NCT00748358 2013-09-18
PROSUT
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT00299741 2012-12-19
Study of SU11248 in Men With Advanced Prostate Cancer
Massachusetts General Hospital
Phase 2 Completed
NCT00790595 2012-07-31
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy
Jonsson Comprehensive Cancer Center
Phase 1 Completed
NCT00137436 2011-08-29
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer
Pfizer
Phase 1/2 Completed